Makers of Nurofen ran 'misleading and deceptive' campaign against Panadol: court


The Federal Court has found that claim to be misleading and deceptive, after two pharmaceutical giants went head-to-head in a two-year legal battle. GlaxoSmithKline, the makers of Panadola , alleged Nurofen's manufacturer, Reckitt Benckisera , ran an advertising campaign saying Nurofen was faster and more effective than Panadol, or paracetamol, despite there being no scientific evidence to support it.



from Biotech News